Table 1.
Characteristics of studies (n = 6).
| Author-year (trial) |
Age (years) |
Male (%) |
NIHSS Score at baseline |
IV t-PA (%) |
Endovascular technique |
GA group |
CS group |
N |
Conversion Rate (%)¶ |
Country | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A (%) | B (%) | C (%) | ||||||||||
| Löwhagen Hendén et al. (15) (Anstroke) | 73 vs. 72 | 58 vs. 51 | 20 vs. 17 | 73 vs. 80 | NR | NR | NR | S, R | R | 90 | 15.6 | Sweden |
| Maurice et al. (19) (GASS) | 71 vs. 73 | 47 vs. 44 | 16 vs. 16 | 66 vs. 65 | NR | NR | NR | P,R | R | 345 | 4.5 | France |
| Ren et al. (18) | 69 vs. 69 | 54 vs. 57 | 14 vs. 14 | 77 vs. 81 | NR | NR | NR | P, R, D | P,D,F | 130 | 9.5 | China |
| Schönenberger et al. (14) (SIESTA) | 72 vs. 71 | 66 vs. 55 | 17 vs. 17 | 63 vs. 65 | 82 vs. 86 | 8 vs. 5 | 22 vs. 16 | NR | NR | 150 | 14.3 | Germany |
| Simonsen et al. (16) (GOLIATH) | 71 vs. 72 | 55 vs. 48 | 18 vs. 17 | 77 vs. 73 | 22 vs. 19 | 39 vs. 38 | 17 vs. 16 | P,R | P,F | 128 | 6.3 | Demark |
| Sun et al. (17) (CANVAS) | 67 vs. 60 | 65 vs. 65 | 14 vs. 13 | 45 vs. 55 | 10 vs. 15 | 40 vs. 45 | 50 vs. 40 | P,R | P,Su | 40 | 20 | China |
NR, not reported; GA, general anesthesia; CS, conscious sedation; IV, intravenous; NIHSS; A: stent retriever; B: direct aspiration; C: stent retriever combined with direct aspiration;
¶
Conversion to general anesthesia; NIHSS, National Institutes of Health Stroke Scale; P, propofol; F, fentanyl; R, remifentanil; D, dexmedetomidine; S, sevoflurane; Su, sufentanil.